Innovision IPO GMP: Key Details and Subscription Status

Innovision IPO Opens with Promising Subscription Rates

Innovision Ltd’s initial public offering (IPO) opened for public subscription on March 10, 2026, and is set to close on March 12, 2026. The company aims to raise ₹322.84 crore through this offering, with a price band set between ₹521 and ₹548 per share. As of March 11, 2026, the IPO has been subscribed at a rate of 12%, indicating a positive reception from investors.

Subscription Breakdown

The subscription figures reveal varied interest across different investor categories. Retail Individual Investors (RIIs) have booked only 6% of the available shares, while Qualified Institutional Buyers (QIBs) show a robust subscription rate of 96%. This disparity highlights the differing appetites for shares among retail and institutional investors.

GMP and Expected Listing Price

As of today, the Grey Market Premium (GMP) for the Innovision IPO stands at ₹71 per share. This premium suggests that the estimated listing price of the stock could be around ₹619 apiece, reflecting a potential gain for early investors. Such figures are often closely watched by market participants as they can indicate the anticipated performance of the stock post-listing.

Key Dates for Investors

Investors should note that the allotment date for the Innovision IPO is set for March 13, 2026, with the listing date following shortly on March 17, 2026. These dates are crucial for those who participate in the IPO, as they will determine the allocation of shares and the subsequent trading opportunities.

Innovision Ltd, based in Gurgaon, is an integrated facility management company. The firm has positioned itself in a growing sector, which may contribute to the interest seen in its IPO. The company’s performance and strategic direction will be closely monitored by investors as it moves forward.

Market Reactions and Future Expectations

Market observers are keenly watching the subscription trends and GMP as the IPO progresses. The strong interest from QIBs may bode well for the stock’s performance upon listing, although the lower subscription from RIIs raises questions about retail investor confidence. Details remain unconfirmed regarding how these dynamics will play out in the coming days.

As the Innovision IPO approaches its closing date, the current subscription rates and GMP provide a snapshot of investor sentiment. With significant institutional backing, the company is poised for a noteworthy entry into the public market, but the final outcomes will depend on the remaining days of the subscription period.